Discovery and characterization of an HIV-1 Tat antagonist

Author:

Hsu Ming-Chu1,Schutt Andrew D.1,Holly Maureen1,Slice Lee W.1,Sherman Michael I.1,Richman Douglas D.2,Potash Mary Jane3,Volsky David J.3

Affiliation:

1. Department of Virology, Hoffmann-La Roche Inc., Nutley, NJ 07110, U.S.A.

2. Infectious Diseases Section, VA Medical Center, University of California, San Diego, CA 92161, U.S.A.

3. Molecular Virology Laboratory, St. Luke's/Roosevelt Hospital Center, Columbia University, New York, NY 10019, U.S.A.

Publisher

Portland Press Ltd.

Subject

Biochemistry

Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. RNA glycosidase and other agents target Tat to inhibit HIV-1 transcription;Biochemical Journal;2018-03-20

2. Improving combination antiretroviral therapy by targeting HIV-1 gene transcription;Expert Opinion on Therapeutic Targets;2016-06-18

3. The Application of Recombinant DNA Technology in Medicinal Chemistry and Drug Discovery;Burger's Medicinal Chemistry and Drug Discovery;2010-09-15

4. Role of Tat Protein in HIV Neuropathogenesis;Neurotoxicity Research;2009-03-21

5. Application of Recombinant DNA Technology in Medicinal Chemistry and Drug Discovery;Burger's Medicinal Chemistry and Drug Discovery;2003-01-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3